🇺🇸 FDA
Patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8163509 (Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P35/00, A61P43/00